AMS企画株式会社
2 known investors
AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
Investors · 2
Frequently asked questions
- What does AMS企画株式会社 do?
- AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.
- Who are AMS企画株式会社's investors?
- AMS企画株式会社's investors include MIRAI SOUZOU, Vision Incubate.